Neuren Pharmaceuticals LimitedASX: NEU

First patient dosed in Neuren PMS Phase 3 trial

Feb 6, 2026 at 3:46 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment